Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-17-335943
Filing Date
2017-11-07
Accepted
2017-11-07 17:30:47
Documents
7

Document Format Files

Seq Description Document Type Size
1 FORM S-3 d489256ds3.htm S-3 309610
2 EX-1.1 d489256dex11.htm EX-1.1 198856
3 EX-4.2 d489256dex42.htm EX-4.2 351500
4 EX-4.3 d489256dex43.htm EX-4.3 389352
5 EX-5.1 d489256dex51.htm EX-5.1 13351
6 EX-12.1 d489256dex121.htm EX-12.1 26282
7 EX-23.1 d489256dex231.htm EX-23.1 1992
  Complete submission text file 0001193125-17-335943.txt   1291879
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-3 | Act: 33 | File No.: 333-221402 | Film No.: 171184517
SIC: 2834 Pharmaceutical Preparations